School of Nursing, The Hong Kong Polytechnic University
Hung Hom, Kowloon, Hong Kong
NCT Number: NCT02027194
The aim of this study is to test and compare the effectiveness between three groups - Cure-Allergic Rhinitis Syrup (CS), Yuk ping fung San (YS) and placebo groups - of adolescents (nursing students) with Allergic Rhinitis (AR) in improving their symptoms of AR, body constitution pattern and health-related quality of life.
• The hypothesis are to test the effectiveness of the CS treatment on these students' AR symptoms and quality of life at immediately, one month and two months after completion of the 4-week intervention, when compared with the YS treatment and placebo group.
1. Cure-Allergic Rhinitis Syrup (CS) group will show significantly reduction of AR symptoms over the 2-month follow-up, when compared to those in YS and placebo groups. 2. CS group will indicate a healthier body constitution pattern over the follow-up, when compared to those with YS and placebo group. 3. CS group will indicate significantly greater improvement of their quality of life over 2-month follow-up, when compared to those with YS and placebo group.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Phase 1 / Phase 2
Hung Hom, Kowloon, Hong Kong
Background
Methodology
Sampling
Intervention
Ethical issues
Instruments
o 60 items of Constitution in Chinese Medicine Questionnaire can assess the participants' body constitution.
Data Collection
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
of the participants are:
Exclusion criteria
of these students include those who have:
Delivered one bottle for two weeks to the participants twice
Other names: CS group
Delivered one bottle for 2-week usage to the participants twice
Other names: YS group
Delivered one bottle (wheat power with favors) for 2-week usage to the participants twice
Other names: Placebo/Control
Time frame: Baseline
10cm visual analogue scale used in a 28-item questionnaire to evaluate their symptoms severity.
Time frame: Immediately after intervention (1-2 min)
10cm visual analogue scale used in a 28-item questionnaire to evaluate their symptoms severity.
Time frame: 1 month after intervention
10cm visual analogue scale used in a 28-item questionnaire to evaluate their symptoms severity.
Time frame: 3 months after intervention
10cm visual analogue scale used in a 28-item questionnaire to evaluate their symptoms severity.
Time frame: Baseline
A 28-item health-related-quality of life questionnaire will be used to evaluate QOL.
Time frame: Baseline
A 60-item questionnaire assesses the participants' patterns of body constitution.
Time frame: Immediately after intervention (1-2 min)
A 28-item health-related quality of life questionnaire will be used to evaluate the participants' disease-specific quality of life.
Time frame: 1 month after intervention
A 28-item health-related quality of life questionnaire will be used to evaluate the participants' disease-specific quality of life.
Time frame: 3 months after intervention
A 28-item health-related quality of life questionnaire will be used to evaluate the participants' disease-specific quality of life.
Time frame: Immediately after intervention (1-2 min)
A 60-item questionnaire will be used to assess the participants' patterns of body constitution.
Time frame: 1 month after intervention
A 60-item questionnaire will be used to assess the participants' patterns of body constitution.
Time frame: 3 month after intervention
A 60-item questionnaire will be used to assess the participants' patterns of body constitution.
Time frame: Baseline
Basic vital signs, urine test, and respiratory functions
Time frame: Immediately after intervention (1-2-min)
Basic vital signs, urine test, and respiratory functions will be taken.
Time frame: 1 month after intervention
Basic vital signs, urine test, and respiratory functions will be taken.
Time frame: 3 months after intervention
Basic vital signs, urine test, and respiratory functions will be taken.
The Hong Kong Polytechnic University
Other
Effects of Chinese Herbal Medicine for Treatment of Allergic Rhinitis: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03075917
Allergic Rhinitis, Hypersensitivity
Bagnols-sur-Cèze, France
View Trial DetailsNCT05346718
Allergic Rhinitis, Birch Pollen Allergy
Hanover, Lower Saxony, Germany
View Trial DetailsNCT06916884
Allergic Rhinitis, Hypersensitivity
Mexico City, Mexico
View Trial DetailsNCT05476484
Allergic Rhinitis, Allergy
Hørsholm, Copenhagen, Denmark
View Trial Details